Search Results
Aug 24, 2026, 08:30 ET Zoomcar and Uber partner to give travelers more ways to plan road trips
or prospect set forth in this press release can or will be achieved. You are also encouraged to carefully review Zoomcar's Annual Report on Form 10- K for the year ended March 31, 2026, and other filings with the U.S. Securities and Exchange Commission for a more comprehensive discussion of risks and
More news about: Zoomcar
Aug 24, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.85 Million Tokens, and Total Crypto and Total Cash Holdings of $14.9 Billion
forward-looking statements based on a number of factors, including those described above and in the Risk Factors section of the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2025 filed with the SEC on November 21, 2025, the Company's Quarterly Reports on Form 10-Q, and the Company's
More news about: Bitmine Immersion Technologies, Inc.
Aug 24, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.85 Million Tokens, and Total Crypto and Total Cash Holdings of $14.9 Billion
forward-looking statements based on a number of factors, including those described above and in the Risk Factors section of the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2025 filed with the SEC on November 21, 2025, the Company's Quarterly Reports on Form 10-Q, and the Company's
More news about: Bitmine Immersion Technologies, Inc.
Aug 24, 2026, 08:30 ET 9/11 Day Launches Nationwide Campaign Calling on Americans to "UNIITE For Good" in Honor of the 25th Anniversary of 9/11
is being provided by AmeriCorps and the Popeyes Foundation℠.More than 70 percent of the grant funding is being directed to youth organizations, K–12 schools, universities and other educational institutions, reflecting 9/11 Day's emphasis on ensuring that a new generation understands the legacy of
More news about: 9/11 Day
Aug 24, 2026, 08:30 ET Bitmine Immersion Technologies anuncia que sus tenencias de ETH alcanzan los 5,85 millones de tokens
a diversos factores, incluidos los descritos anteriormente y en la sección de Factores de Riesgo del Informe Anual de la compañía en el Formulario 10-K para el año fiscal que finalizó el 30 de septiembre de 2025, presentado ante la SEC el 21 de noviembre de 2025, los Informes Trimestrales de la compañía
More news about: Bitmine Immersion Technologies, Inc.
Aug 24, 2026, 08:15 ET BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions
whether BrainStorm's future interactions with the FDA will have productive outcomes, and other factors detailed in BrainStorm's annual report on Form 10-K and quarterly reports on Form 10-Q available at http://www.sec.gov. These factors should
More news about: BrainStorm Cell Therapeutics Inc.
Aug 24, 2026, 08:08 ET Rocket One Inc. to Attend IDGA's Counter UAS Summit August 25 - 26, 2026
are described in the Company's filings with the Securities and Exchange Commission ("SEC") including the Company's most recent Annual Report on Form 10-K and the Company's other filings made with the SEC. Although the Company believes that the expectations reflected in the forward-looking statements are
More news about: Rocket One Inc.
Aug 24, 2026, 08:00 ET Regent to Acquire Avon North America, Reuniting Major Avon Businesses After More Than a Decade Apart
Avon International back together under common ownership for the first time since 2016, while enabling LG H&H to further focus on its core global K-beauty and retail priorities.SEOUL, NEW YORK, LOS ANGELES & LONDON, Aug.
More news about: The Avon Company
Aug 24, 2026, 08:00 ET AZENTA ANNOUNCES LEADERSHIP TRANSITION
Company's filings with the Securities and Exchange Commission, including but not limited to its Annual Report on Form 10 K, Quarterly Reports on Form 10 Q and Current Reports on Form 8 K. Because forward looking statements relate to future events and are based on current expectations, they are inherently
More news about: Azenta
Aug 24, 2026, 08:00 ET LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
Report on Form 10-K for the fiscal year ended December 31, 2024 and in our subsequent reports on Form 10-Q and Form 10-K, in each case including in the sections thereof captioned "Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in our subsequent reports on Form 8-K. Except as required
More news about: Eisai Inc.
Aug 24, 2026, 08:00 ET Innovative Eyewear, Inc. Announces Strategic Alliance with HTC Corporation
forward-looking statements are set forth in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K under the caption "Risk Factors."Investor Relations Contact:Skyline Corporate Communications Group, LLCScott Powell, President1177
More news about: Innovative Eyewear, Inc.
Aug 24, 2026, 08:00 ET Kimbell Royalty Partners Boosts 2026 Production Guidance
from and to integrate acquired assets, including the assets acquired in the Acquisition; and other risks described in Kimbell's Annual Report on Form 10-K and other filings with the SEC, available at the SEC's website at www.sec.gov. You are cautioned
More news about: Kimbell Royalty Partners, LP
Aug 24, 2026, 08:00 ET Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth
clinical enrollment of the ReachTact® TAVR Assistance System continued to progress.Overseas, DCwire® Micro Guidewire received 510(k) clearance from the U.S. Food and Drug Administration ("FDA"). GeminiOne® has submitted its European Union Medical Device Regulation ("EU
More news about: Peijia Medical
Aug 24, 2026, 08:00 ET Avulux Granted FDA De Novo Authorization, Creating the First Lens Classification for Migraine-Associated Light Sensitivity
Photophobia in neurologic disorders. Translational Neurodegeneration. 2017;6:26. doi:10.1186/s40035-017-0095-34 Brennan KC, Digre K. Shedding Light on Photophobia Journal of Neuro-Ophthalmology. 2012;32(1):68-81. doi:10.1097/WNO.0b013e31824745485 Onofri A, Pensato
More news about: Avulux
Aug 24, 2026, 08:00 ET PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile
scientific approach and general development progress; and the factors discussed in the "Risk Factors" section of PTC's most recent Annual Report on Form 10-K, as well as any updates to these risk factors filed from time to time in PTC's other filings with the SEC. You are urged to carefully consider all such
More news about: PTC Therapeutics, Inc.
Aug 24, 2026, 08:00 ET AIxC's RoboShare Secures New Short- and Long-Term Orders, Plans to Build North America's Largest and Most Diverse Robot-Sharing Platform
uncertainties are described more fully in our filings with the U.S. Securities and Exchange Commission (the "SEC"), including our Annual Report on Form 10-K for the year ended December 31, 2025, our Quarterly Reports on Form 10-Q, and our subsequent filings, which are available on the SEC's website at
More news about: AIxCrypto Holdings, Inc.
Aug 24, 2026, 07:30 ET Innovative Eyewear Announces Expansion Into More than 150 Stores of One of the Largest Big Box Retailers in the United States
forward-looking statements are set forth in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K under the caption "Risk Factors."Investor Relations Contact:Scott PowellSkyline Corporate Communications Group, LLCOffice:
More news about: Innovative Eyewear, Inc.
Aug 24, 2026, 07:24 ET Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology
2027."Blood-based biomarker testing has rapidly set a new standard of care for guiding treatment and diagnosis decisions for Alzheimer's disease," said Michael K. Racke, MD, a board-certified neurologist and senior medical director, neurology, Quest Diagnostics. "As one of the pioneers in this field, Quest is constantly
More news about: Quest Diagnostics
Aug 24, 2026, 07:05 ET REGENXBIO Announces Regulatory Update on RGX-121 for MPS II
Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of REGENXBIO's Annual Report on Form 10-K for the year ended December 31, 2025, and comparable "risk factors" sections of REGENXBIO's Quarterly Reports on Form 10-Q and other filings, which have
More news about: REGENXBIO Inc.
Aug 24, 2026, 07:02 ET Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings
Form 10-K under the heading RISK FACTORS and in the company's other filings with the SEC. The information in this press release should be read in conjunction with a review of the company's filings with the SEC including the information in the company's most recent Annual Report on Form 10-K under the
More news about: Labcorp
Aug 24, 2026, 07:00 ET Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission
Financial Condition and Results of Operations" sections of Vanda's most recent Annual Report on Form 10-K, as updated by Vanda's subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the U.S. Securities and Exchange Commission, which are available at
More news about: Vanda Pharmaceuticals Inc.
Aug 24, 2026, 07:00 ET BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
uncertainties that may affect the Company's business, please see the factors discussed in Item 1A, "Risk Factors," in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and any subsequent Company filings with the Securities and Exchange Commission (SEC). The Company cautions
More news about: Insmed Incorporated
Aug 24, 2026, 07:00 ET NAPCO Security Technologies, Inc. Reports Fiscal Q4 and Full Year 2026 Results
factors, including those risk factors set forth in the Company's filings with the Securities and Exchange Commission, such as our annual report on Form 10-K and quarterly reports on Form 10-Q. Other unknown or unpredictable factors or underlying assumptions subsequently proved to be incorrect could cause actual
More news about: NAPCO Security Technologies, Inc.
Aug 24, 2026, 06:51 ET K2view Positioned as a Leader & Ace Performer in the SPARK Matrix™: Enterprise Data Fabric, 2026 by QKS Group
SPARK Matrix™: Enterprise Data Fabric, 2026About K2view:K2view delivers real-time, trusted data to the enterprise's most critical operational and AI workloads. Its entity-based Micro-Database architecture
More news about: QKS Group
Aug 24, 2026, 05:50 ET X Financial Reports Second Quarter 2026 Unaudited Financial Results
unaudited financial results for the second quarter ended June 30, 2026. This press release should be read in conjunction with the Company's Report on Form 6-K for the second quarter ended June 30, 2026, which has been furnished to the U.S. Securities and Exchange Commission and is available on the SEC's website
More news about: X Financial